Receptor Life Sciences
PrivateLast Round
Series A
Extension
Apr 7, 2022
Total Funding Raised
$38.7M
Company Overview
Receptor Life Sciences is a pharmaceutical company that develops innovative therapies for central nervous system disorders using FDA-approved drug delivery technologies for cannabinoid products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Receptor Life Sciences Comparables
Compare Receptor Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ANANDA Scientific | 79% | |
| UCB | 76% | |
| Synendos Therapeutics | 71% |
Receptor Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 7, 2022 | ||||
| Series A | Oct 29, 2018 |
Receptor Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granite Point Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2022
$9.7M round led by Granite Point Capital
- Oct 29, 2018
$29M round completed.
Receptor Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Receptor Life Sciences's valuation, stock price, and market status.
Is Receptor Life Sciences a public or private company?
Receptor Life Sciences is a private company.
What is the current stock price of Receptor Life Sciences?
Receptor Life Sciences is a private company with no public stock price. Caplight tracks Receptor Life Sciences's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Receptor Life Sciences worth (valuation)?
Valuation information for Receptor Life Sciences is not publicly available.
Can I buy Receptor Life Sciences stock?
Receptor Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Receptor Life Sciences's last funding round?
Receptor Life Sciences's most recent funding round was Series A Extension on April 7, 2022.
Who are the main investors in Receptor Life Sciences?
Key investors in Receptor Life Sciences include Granite Point Capital.
Will Receptor Life Sciences IPO soon?
No public IPO plans have been announced for Receptor Life Sciences.
How can I track Receptor Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Receptor Life Sciences's secondary market activity and sign up for updates.